Lin Shao-Lee bought CUE
August 12, 2026 · Form 4 insider transaction
Lin Shao-Lee bought 109,179 shares of Cue Biopharma, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
109,179
Price
$0.00
Total value
N/A
InsiderLin Shao-Lee
RoleOfficer, Director
CompanyCue Biopharma, Inc. (CUE)
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateAugust 12, 2026
Filing dateAugust 14, 2026
Shares owned after764,253
OwnershipDirect
10b5-1 planNo
AmendedNo